-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711. Cell Collection and Processing: Poster III Clinically Relevant Abstract

Symposia: Cell Collection and Processing Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)
4890
Constructing a Machine Learning-Based Rating Model to Predict the Outcome of GCSF Mobilization of Hematopoietic Stem Cells in Peripheral BloodClinically Relevant Abstract

Xiangjun Zeng1*, Jimei Ge1*, Jimin Shi2*, Yi Luo1, Jian Yu1*, Xiaoyu Lai1*, Lizhen Liu1*, Yamin Tan, MD3*, Huarui Fu4*, Pengxu Qian, PhD5*, He Huang6* and Yanmin Zhao, MD1*

1The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Hangzhou, China
2Institute of Hematology, Zhejiang University, Hangzhou, China
3Zhejiang Cancer Hospital, Hangzhou, China
4Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University, Hangzhou, China
6The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4891
The Combination of Pegfilgrastim and Filgrastim Improves the Outcomes of Mobilization and Engraftment after Transplantation of Autologous Hematopoietic Stem Cells for the Treatment of LymphomaClinically Relevant Abstract

Xingtong Wang, MD1, Wei Guo2*, Yangzhi Zhao, MD/PhD2*, Jia Li3, Xin Wan, MD2* and Ou Bai, MD/PhD2*

1Department of Hematology, The First Hospital of Jilin University, Changchun, KY, China
2Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China
3Department of Hematology, The First Hospital of Jilin University, Changchun, China
4892
Delivery of Obecabtagene Autoleucel (obe-cel, AUTO1) for the FELIX Pivotal Study Demonstrating Robust Cell Processing, Robust Release Testing, and Reliable Logistics, Together with Readiness for Sustainable Patient (pt) CareClinically Relevant Abstract

Mike Merges, MSc*, David Brochu, BPharm*, Chris Gray, BA*, Claudia Mercedes-Mayer, MEng*, Chris Fong, BSc*, Markus Gruell, MSc*, Elaine Dymond, MSc, QP*, Koki Lilova, PhD*, Mei Mei Fung, MSc*, Gerardo Santiago-Toledo, PhD* and Gavin Addy, MPharm*

Autolus Therapeutics, London, United Kingdom
4893
The Non-Hematopoietic Content in Paediatric Autologous Hematopoietic Stem Cell Grafts Is Skewed Towards Regulatory Myeloid and Exhausted PhenotypesClinically Relevant Abstract

Cora L Geiger, MSc1*, Alexandra Koshyk2*, Taylor Harris2*, Madison Denney1,2*, Chant Katrjian2*, Karin G. Hermans, PhD3*, Tristan E Knight, MD4* and Donna Wall, MD1

1University of Toronto, Toronto, Canada
2SickKids, Toronto, Canada
3SickKids, Toronto, CAN
4University of Washington, Seattle
4894
Serum Ferritin Levels Prior to Mobilization and Collection May Not Influence Stem Cell YieldClinically Relevant Abstract

Charles Weeks1, Danielle Bradshaw, MD2*, Sujith Abbagoni3*, Mohammad Mian, PhD4*, Sarah Jimenez, MSN, NP5*, Courtney Corley, BSN, RN5*, Amany R. Keruakous, MD, MS6, Ayushi Chauhan, MD6, Locke Johnson Bryan, MD6, Jorge Cortes, MD6, Anand Jillella, MD6 and Vamsi K. Kota, MD6

1Medical College of Georgia, Augusta, GA
2Augusta University, Augusta, GA
3Medical College of Georgia, Augusta
4Georgia Cancer Center, augusta, GA
5Georgia Cancer Center, Augusta, GA
6Georgia Cancer Center, Augusta University, Augusta, GA
See more of: Oral and Poster Abstracts
<< Previous Session | Next Session >>
*signifies non-member of ASH